Conversion to Alzheimer’s disease could not be analyzed specifically, as most of the articles examining conversion either did not define Alzheimer’s disease or the definition was based on neuropsychological testing but not on biomarkers (i.e., Aβ and p-tau status were assessed only at baseline). This evidence concerns the gene MAPT and Alzheimer disease.